Free Trial

Sharecare (NASDAQ:SHCR) Sets New 12-Month High at $1.40

Sharecare logo with Medical background

Sharecare, Inc. (NASDAQ:SHCR - Get Free Report)'s share price reached a new 52-week high during trading on Tuesday . The company traded as high as $1.40 and last traded at $1.40, with a volume of 139016 shares. The stock had previously closed at $1.39.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Canaccord Genuity Group restated a "hold" rating and set a $1.43 price objective (down from $2.00) on shares of Sharecare in a research report on Friday, June 21st. Morgan Stanley upped their price target on shares of Sharecare from $1.00 to $1.43 and gave the stock an "equal weight" rating in a research note on Monday, June 24th. Finally, Canaccord Genuity Group lowered Sharecare from a "strong-buy" rating to a "hold" rating in a research report on Friday, June 21st.

Read Our Latest Report on SHCR

Sharecare Price Performance

The company has a market cap of $503.75 million, a price-to-earnings ratio of -3.76 and a beta of 0.50. The business has a 50-day simple moving average of $1.38 and a two-hundred day simple moving average of $1.03.

Sharecare (NASDAQ:SHCR - Get Free Report) last announced its quarterly earnings results on Friday, August 9th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.03). Sharecare had a negative net margin of 33.64% and a negative return on equity of 22.81%. The company had revenue of $94.27 million for the quarter, compared to analyst estimates of $90.16 million. As a group, equities analysts anticipate that Sharecare, Inc. will post -0.24 earnings per share for the current year.


Insider Buying and Selling at Sharecare

In related news, insider Jeffrey T. Arnold sold 177,085 shares of the company's stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $1.38, for a total value of $244,377.30. Following the sale, the insider now owns 4,790,406 shares of the company's stock, valued at $6,610,760.28. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 29.27% of the company's stock.

Institutional Trading of Sharecare

Several hedge funds have recently bought and sold shares of the stock. Truist Financial Corp bought a new stake in shares of Sharecare during the 4th quarter worth about $29,000. Bfsg LLC increased its stake in Sharecare by 115.1% in the first quarter. Bfsg LLC now owns 82,230 shares of the company's stock valued at $63,000 after acquiring an additional 44,000 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Sharecare by 47.2% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 635,288 shares of the company's stock worth $488,000 after buying an additional 203,843 shares during the last quarter. StoneX Group Inc. acquired a new position in Sharecare during the first quarter worth about $102,000. Finally, Private Management Group Inc. lifted its stake in Sharecare by 127.4% in the 1st quarter. Private Management Group Inc. now owns 9,284,572 shares of the company's stock valued at $7,126,000 after purchasing an additional 5,201,296 shares during the last quarter. 35.08% of the stock is currently owned by institutional investors and hedge funds.

About Sharecare

(Get Free Report)

Sharecare, Inc operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being.

Featured Stories

Should you invest $1,000 in Sharecare right now?

Before you consider Sharecare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sharecare wasn't on the list.

While Sharecare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Tesla Stock: Profits vs. Price—Is It Time to Sell?

Tesla Stock: Profits vs. Price—Is It Time to Sell?

Find out why some believe it might be time to move on from Tesla stock, while others still see potential in its long-term growth.

Related Videos

Top Stocks to Buy, Sell, and Hold Right Now
Tesla Stock Dip: A Buyer’s Alert
Opportunities Arise as Stock Market Rotates from Big Tech

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines